Navegando por Data de Publicação, começando com "2007-12-17"
Agora exibindo 1 - 3 de 3
- Resultados por página
- Opções de Ordenação
listelement.badge.dso-typeItem, A carnalidade da reflexão: ipseidade e alteridade em Merleau-Ponty(Universidade Federal de São Carlos, 2007-12-17) Silva, Claudinei Aparecido de Freitas da; Monzani, Luiz Roberto; https://lattes.cnpq.br/2036732603638197Dans quel sens, le fait de circonscrire les notions d ipséité et d altérité par le moyen de l expérience de la carnalité devient-il légitime? Dans quelle mesure, le rôle de la perception, du propre corps, du langage, du temps, de la vision configurent un essai fondamental à cette circonscription ? Ce sont ces thèmes émergents que la présente recherche se propose de caractériser, à la lumière de la philosophie de Maurice Merleau-Ponty. Cette philosophie, du début à la fin, animée par une interrogation radicale portant sur l exercice de la réflexion dans sa transfiguration corporelle et intersubjective, sous l horizon ultime d une réhabilitation ontologique du sensible . C est cette question-énigme centrale que Merleau-Ponty cherche à traduire sous l idée de carnalité comme exigence de fond à laquelle se destine la signification dernière de la Raison, mise à l ordre du jour par la pensée contemporaine.listelement.badge.dso-typeItem, Caracterização microestrutural, morfológica e óptica de filmes anódicos de ZrO2(Universidade Federal de São Carlos, 2007-12-17) Strixino, Francisco Trivinho; Souza, Ernesto Chaves Pereira de; https://lattes.cnpq.br/1505400360366643; https://lattes.cnpq.br/9740223649776400In this work, we described some of the anodic ZrO2 properties such as microstructure, morphology and luminescence. The microstructural analysis during the breakdown process reveals that the oxide nature is similar to those oxides prepared by other methods. Nevertheless, a transition in the breakdown region is associated with the presence of crystallographic phases not stable at ambient temperature (tetragonal metastable phase). These results were explained in terms of changes in the crystallite size and microstructural of the oxide during the breakdown process. The morphology of the anodic oxides reveals a surface contained a high distribution of blisters structure. The adsorption of oxygen gas originated from the electrolysis of water modifies the oxide morphology at that spots location. A broad emission band between 350-600 nm is observed in ZrO2 films when excited at 325 nm. The origin and nature of this emission is proposed to be related to the existence of structure defects (F-centers and Zr3+ ions) inside the oxide generated during the breakdown process. Theories about the breakdown mechanism and the analyses of the Rapid Thermal Annealing and EPR data reinforced this proposition. The work was finalized with the production of anodic doped ZrO2 with Eu3+. The microstructural analysis reveals that these luminescent ions are located inside the oxide matrix and the anodic doping was explained in terms of the breakdown process.listelement.badge.dso-typeItem, Papel dos receptores GABA-benzodiazpínicos da amigdala na modulação da ansiedade em camundongos ingênuos e reexpostos ao labirinto em cruz elevado(Universidade Federal de São Carlos, 2007-12-17) Barbalho, Cilene Aparecida; Souza, Azair Liane Matos do Canto de; https://lattes.cnpq.br/2352004564367849; https://lattes.cnpq.br/7206285334603986Previous studies demonstrated that microinjections of midazolam (MDZ), GABAAbenzodiazepine (BDZs) receptor agonist, into the amygdala (AMY) produce anxiolytic effects in the elevated plus-maze (EPM) naïve-mice. During the reexposured to the EPM is increasing avoidance of open arms and impairs the anxiolytic like effect of BDZs, phenomenon characterized as "one trial tolerance" (OTT). This study investigated the effects of intra-AMY infusions of midazolam (MDZ) in EPM-experienced mice and GABAA-BDZs receptor antagonist, flumazenil (FMZ), intra-AMY, on anxiety in EPM-naïve and EPMexperienced mice. The analysis was performed on conventional measures of anxiety (% open arm entries and % open arm time), locomotor activity (frequency of closed arm entries) and a range of ethological measures related to risk assessment. The intra-AMY infusions of MDZ (3.0 and 30 nmol/0.1µl) increased % open arm entries (%OA) and % open arm time (%OT) in EPM-experienced mice. The analysis of ethological measures demonstrated that MDZ increased the total head dipping (THD) and decreased percent protected head dipping (%PHD) and percent protected stretched attend postures (%PSAP) without any significant change to total stretched attend (TSAP), total rearing (TR) and total immobility (TI). The intra-AMY infusions of FMZ 16 (nmol/0.1µl), increased %OA and %OT in maze-naïve and maze-experienced mice. The analysis of ethological measures reveals that FMZ increased the THD and TSAP and decreased %PHD and %PSAP without any significant change to TSAP, TR and TI in maze-naïve. In EPM-experienced mice, intra-AMY infusions of FMZ only increased TSAP without alter any other ethological measure. Interestingly, combined administration of DMCM (1.0 mg/Kg) and FMZ (2.0 nmol) significantly decreased the %OA and %OT when compared to vehicle+vehicle. The anxiogenic-like effect produced by GABAA receptor inverse agonist was blocked by intra-AMY infusions of FMZ. FMZ plus vehicle produced absence of effects. These effects were observed in the absence of significant changes in locomotor activity, indicating a selective anxiolytic-like effect for MDZ and FMZ. Interestingly, both benzodiazepine receptor agonist and antagonist, MDZ and FLU, respectively, produced selective anxiolytic-like effects when injected into the amygdala in maze-experienced mice. Together, present results demonstrate that GABA-benzodiazepine receptor complex located within the AMY did not involvement in the OTT phenomenon. However, the anxiogenic-like effect produced by GABA-BDZs receptor inverse agonist was blocked by intra-AMY infusions of FMZ. These results suggest that the emotional state induced by plus-maze test someway releases endogenous benzodiazepine receptor inverse agonist within the amygdala.